---
title: "Nukkleus - CW27 | 10-Q: FY2025 Q2 Revenue: USD 0"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/253103754.md"
published_at: "2025-08-14T21:08:17.000Z"
---

# Nukkleus - CW27 | 10-Q: FY2025 Q2 Revenue: USD 0

Revenue: As of FY2025 Q2, the actual value is USD 0.

EPS: As of FY2025 Q2, the actual value is USD 0.54.

EBIT: As of FY2025 Q2, the actual value is USD 3.237 M.

### Operating Expenses

-   **Professional Fees**: For the three months ended June 30, 2025, professional fees decreased by approximately $144,000, or 16.3%, compared to the same period in 2024. For the six months ended June 30, 2025, professional fees decreased by approximately $1,022,000, or 37.6%.
-   **Compensation and Related Benefits**: For the three months ended June 30, 2025, compensation and related benefits increased by approximately $46,000, or 186.0%, compared to the same period in 2024. For the six months ended June 30, 2025, compensation and related benefits increased by approximately $80,000, or 145.5%.
-   **Other General and Administrative Expenses**: For the three months ended June 30, 2025, other general and administrative expenses increased by approximately $116,000, or 95.1%, compared to the same period in 2024. For the six months ended June 30, 2025, these expenses increased by approximately $382,000, or 110.6%.

### Other Income (Expense)

-   **Interest Expense**: For the three months ended June 30, 2025, interest expense increased by approximately $167,000, or 421.4%, compared to the same period in 2024. For the six months ended June 30, 2025, interest expense increased by approximately $332,000, or 835.9%.
-   **Change in Fair Value – Stock Purchase Warrant Liabilities**: For the six months ended June 30, 2025, there was a gain of approximately $109,406,000.

### Cash Flow

-   **Net Cash Used in Operating Activities**: For the six months ended June 30, 2025, net cash used in operating activities was approximately $2,694,000, compared to $1,821,000 for the same period in 2024.
-   **Net Cash Used in Investing Activities**: For the six months ended June 30, 2025, net cash used in investing activities was approximately $1,515,000.
-   **Net Cash Used in Financing Activities**: For the six months ended June 30, 2025, net cash used in financing activities was approximately $878,000.

### Future Outlook and Strategy

-   **Core Business Focus**: The company plans to focus on the defense sector following the acquisition of Star 26 Capital Inc., which is expected to be completed near the end of the third quarter of 2025.
-   **Non-Core Business**: The company is in the process of divesting its financial services segment, with the sale of its subsidiary DRFQ expected to be completed in the third quarter of 2025.

### Related Stocks

- [NUKKW.US - Nukkleus - CW27](https://longbridge.com/en/quote/NUKKW.US.md)
- [DFNSW.US - T3 Defense - CW27](https://longbridge.com/en/quote/DFNSW.US.md)

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.